Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 7941563, 19 pages
https://doi.org/10.1155/2017/7941563
Review Article

Aging: Molecular Pathways and Implications on the Cardiovascular System

Departamento de Ciências Farmacêuticas/Centro de Ciências da Saúde, Universidade Federal da Paraíba, Cidade Universitária-Campus I, Caixa Postal 5009, 58.051-970 João Pessoa, PB, Brazil

Correspondence should be addressed to Isac Almeida de Medeiros; rb.bpfu.ftl@casi

Received 5 May 2017; Accepted 27 June 2017; Published 9 August 2017

Academic Editor: Consuelo Borrás

Copyright © 2017 Arthur José Pontes Oliveira de Almeida et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. UN, “UNDESA Population Division, World population prospects: the 2015 revision,” HelpAge, Global AgeWatch Index 2015: Insight Report, HelpAge International, London WC1A 9GB, UK, 2015. View at Google Scholar
  2. WHO, NCD Mortality and Morbidity, World Health Organization, 2012, http://www.who.int/gho/ncd/mortality_morbidity/en/.
  3. J. Campisi, “Aging, cellular senescence, and cancer,” Annual Review of Physiology, vol. 75, no. 1, pp. 685–705, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. C. López-Otín, M. A. Blasco, L. Partridge, M. Serrano, and G. Kroemer, “The hallmarks of aging,” Cell, vol. 153, no. 6, pp. 1194–1217, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. C. E. Riera, C. Merkwirth, C. D. D. M. Filho, and A. Dillin, “Signaling networks determining life span,” Annual Review of Biochemistry, vol. 85, no. 1, pp. 35–64, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Campisi and F. d'Adda di Fagagna, “Cellular senescence: when bad things happen to good cells,” Nature Reviews Molecular Cell Biology, vol. 8, no. 9, pp. 729–740, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. D. V. Ziegler, C. D. Wiley, and M. C. Velarde, “Mitochondrial effectors of cellular senescence: beyond the free radical theory of aging,” Aging Cell, vol. 14, no. 1, pp. 1–7, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Sagiv and V. Krizhanovsky, “Immunosurveillance of senescent cells: the bright side of the senescence program,” Biogerontology, vol. 14, no. 6, pp. 617–628, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. J. R. Aunan, M. M. Watson, H. R. Hagland, and K. Søreide, “Molecular and biological hallmarks of ageing,” British Journal of Surgery, vol. 103, no. 2, pp. e29–e46, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Vicente, A. L. Mausset-Bonnefont, C. Jorgensen, P. Louis-Plence, and J. M. Brondello, “Cellular senescence impact on immune cell fate and function,” Aging Cell, vol. 15, no. 3, pp. 400–406, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. A. L. Gruver, L. L. Hudson, and G. D. Sempowski, “Immunosenescence of ageing,” The Journal of Pathology, vol. 211, no. 2, pp. 144–156, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Collado, M. A. Blasco, and M. Serrano, “Cellular senescence in cancer and aging,” Cell, vol. 130, no. 2, pp. 223–233, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Oh, Y. D. Lee, and A. J. Wagers, “Stem cell aging: mechanisms, regulators and therapeutic opportunities,” Nature Medicine, vol. 20, no. 8, pp. 870–880, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Abbas, L. Jesel, C. Auger et al., “Endothelial microparticles from acute coronary syndrome patients induce premature coronary artery endothelial cell aging and thrombogenicity: role of the Ang II/AT1 receptor/NADPH oxidase-mediated activation of MAPKs and PI3-kinase pathways,” Circulation, vol. 135, no. 3, pp. 280–296, 2017. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Munoz-Espin and M. Serrano, “Cellular senescence: from physiology to pathology,” Nature Reviews Molecular Cell Biology, vol. 15, no. 7, pp. 482–496, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Lanigan, J. G. Geraghty, and A. P. Bracken, “Transcriptional regulation of cellular senescence,” Oncogene, vol. 30, no. 26, pp. 2901–2911, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. D. J. Baker, B. G. Childs, M. Durik et al., “Naturally occurring p16Ink4a-positive cells shorten healthy lifespan,” Nature, vol. 530, no. 7589, pp. 184–189, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. G. P. Dimri, X. Lee, G. Basile et al., “A biomarker that identifies senescent human cells in culture and in aging skin in vivo,” Proceedings of the National Academy of Sciences, vol. 92, no. 20, pp. 9363–9367, 1995. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Althubiti, L. Lezina, S. Carrera et al., “Characterization of novel markers of senescence and their prognostic potential in cancer,” Cell Death & Disease, vol. 5, article e1528, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Khemais-Benkhiat, N. Idris-Khodja, T. P. Ribeiro et al., “The redox-sensitive induction of the local angiotensin system promotes both premature and replicative endothelial senescence: preventive effect of a standardized Crataegus extract,” The Journals of Gerontology: Series A, vol. 71, no. 12, pp. 1581–1590, 2016. View at Publisher · View at Google Scholar
  21. D. G. A. Burton and V. Krizhanovsky, “Physiological and pathological consequences of cellular senescence,” Cellular and Molecular Life Sciences, vol. 71, no. 22, pp. 4373–4386, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. P. D. Adams, “Healing and hurting: molecular mechanisms, functions, and pathologies of cellular senescence,” Molecular Cell, vol. 36, no. 1, pp. 2–14, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. C. B. Harley, A. B. Futcher, and C. W. Greider, “Telomeres shorten during ageing of human fibroblasts,” Nature, vol. 345, no. 6274, pp. 458–460, 1990. View at Publisher · View at Google Scholar
  24. A. Bernadotte, V. M. Mikhelson, and I. M. Spivak, “Markers of cellular senescence. Telomere shortening as a marker of cellular senescence,” Aging (Albany New York), vol. 8, no. 1, pp. 3–11, 2016. View at Publisher · View at Google Scholar
  25. L. Yue and H. Yao, “Mitochondrial dysfunction in inflammatory responses and cellular senescence: pathogenesis and pharmacological targets for chronic lung diseases,” British Journal of Pharmacology, vol. 173, no. 15, pp. 2305–2318, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. C. D. Wiley, M. C. Velarde, P. Lecot et al., “Mitochondrial dysfunction induces senescence with a distinct secretory phenotype,” Cell Metabolism, vol. 23, no. 2, pp. 303–314, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. D. A. Gewirtz, “Autophagy and senescence,” Autophagy, vol. 9, no. 5, pp. 808–812, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Davalli, T. Mitic, A. Caporali, A. Lauriola, and D. D'Arca, “ROS, cell senescence, and novel molecular mechanisms in aging and age-related diseases,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 3565127, 18 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. M. D. Ross, E. Malone, and G. Florida-James, “Vascular ageing and exercise: focus on cellular reparative processes,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 3583956, 15 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. J. C. Wang and M. Bennett, “Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence,” Circulation Research, vol. 111, no. 2, pp. 245–259, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Tchkonia, Y. Zhu, J. v. Deursen, J. Campisi, and J. L. Kirkland, “Cellular senescence and the senescent secretory phenotype: therapeutic opportunities,” The Journal of Clinical Investigation, vol. 123, no. 3, pp. 966–972, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. F. Fyhrquist, O. Saijonmaa, and T. Strandberg, “The roles of senescence and telomere shortening in cardiovascular disease,” Nature Reviews Cardiology, vol. 10, no. 5, pp. 274–283, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Hayflick and L. Moorhead, “The serial cultivation of human diploid cell strains,” Experimental Cell Research, vol. 25, pp. 585–621, 1961. View at Publisher · View at Google Scholar
  34. J. Maciejowski and T. d. Lange, “Telomeres in cancer: tumour suppression and genome instability,” Nature Reviews Molecular Cell Biology, vol. 18, no. 3, pp. 175–186, 2017. View at Publisher · View at Google Scholar
  35. C. A. Armstrong and K. Tomita, “Fundamental mechanisms of telomerase action in yeasts and mammals: understanding telomeres and telomerase in cancer cells,” Open Biology, vol. 7, no. 3, article 160338, 2017. View at Publisher · View at Google Scholar
  36. P. J. Hohensinner, J. J. Goronzy, and C. M. Weyand, “Telomere dysfunction, autoimmunity and aging,” Aging and Disease, vol. 2, no. 6, pp. 524–537, 2011. View at Google Scholar
  37. K. Muraki, K. Nyhan, L. Han, and J. P. Murnane, “Mechanisms of telomere loss and their consequences for chromosome instability,” Frontiers in Oncology, vol. 2, 2012. View at Publisher · View at Google Scholar
  38. E. H. Blackburn, E. S. Epel, and J. Lin, “Human telomere biology: a contributory and interactive factor in aging, disease risks, and protection,” Science, vol. 350, no. 6265, pp. 1193–1198, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. W. Wright and J. Shay, “The two-stage mechanism controlling cellular senescence and immortalization,” Experimental Gerontology, vol. 27, pp. 383–389, 1992. View at Publisher · View at Google Scholar · View at Scopus
  40. M. T. Hayashi, A. J. Cesare, J. A. J. Fitzpatrick, E. Lazzerini-Denchi, and J. Karlseder, “A telomere dependent DNA damage checkpoint induced by prolonged mitotic arrest,” Nature Structural & Molecular Biology, vol. 19, no. 4, pp. 387–394, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. J. W. Shay and W. E. Wright, “Senescence and immortalization: role of telomeres and telomerase,” Carcinogenesis, vol. 26, no. 5, pp. 867–874, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. M. T. Hayashi, A. J. Cesare, T. Rivera, and J. Karlseder, “Cell death during crisis is mediated by mitotic telomere deprotection,” Nature, vol. 522, no. 7557, pp. 492–496, 2015. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Nandakumar and T. R. Cech, “Finding the end: recruitment of telomerase to the telomere,” Nature Reviews Molecular Cell Biology, vol. 14, no. 2, pp. 69–82, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. D. Hockemeyer and K. Collins, “Control of telomerase action at human telomeres,” Nature Structural & Molecular Biology, vol. 22, no. 11, pp. 848–852, 2015. View at Publisher · View at Google Scholar · View at Scopus
  45. R. M. Marión and M. A. Blasco, “Telomeres and telomerase in adult stem cells and pluripotent embryonic stem cells,” in The Cell Biology of Stem Cells, E. Meshorer and K. Plath, Eds., pp. 118–131, Springer US, Boston, MA, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Yang, S. Przyborski, M. J. Cooke et al., “A key role for telomerase reverse transcriptase unit in modulating human embryonic stem cell proliferation, cell cycle dynamics, and in vitro differentiation,” Stem Cells, vol. 26, no. 4, pp. 850–863, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Bär and M. Blasco, “Telomeres and telomerase as therapeutic targets to prevent and treat age-related diseases [version 1; referees: 4 approved],” F1000Research, vol. 5, 2016. View at Publisher · View at Google Scholar · View at Scopus
  48. J.-K. Yeh and C.-Y. Wang, “Telomeres and telomerase in cardiovascular diseases,” Genes, vol. 7, no. 9, p. 58, 2016. View at Publisher · View at Google Scholar · View at Scopus
  49. F. Sanchis-Gomar and A. Lucia, “Acute myocardial infarction: “telomerasing” for cardioprotection,” Trends in Molecular Medicine, vol. 21, no. 4, pp. 203–205, 2015. View at Publisher · View at Google Scholar · View at Scopus
  50. C. Bär, B. B. d. Jesus, R. Serrano et al., “Telomerase expression confers cardioprotection in the adult mouse heart after acute myocardial infarction,” Nature Communications, vol. 5, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. A. G. Panayiotou, A. N. Nicolaides, M. Griffin et al., “Leukocyte telomere length is associated with measures of subclinical atherosclerosis,” Atherosclerosis, vol. 211, no. 1, pp. 176–181, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. A. L. Serrano and V. Andrés, “Telomeres and cardiovascular disease: does size matter?” Circulation Research, vol. 94, no. 5, pp. 575–584, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. S. A. Booth and F. J. Charchar, “Cardiac telomere length in heart development, function, and disease,” Physiological Genomics, 2017. View at Publisher · View at Google Scholar
  54. G. D. Richardson, D. Breault, G. Horrocks, S. Cormack, N. Hole, and W. A. Owens, “Telomerase expression in the mammalian heart,” The FASEB Journal, vol. 26, no. 12, pp. 4832–4840, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Z. Nazari-Shafti and J. P. Cooke, “Telomerase therapy to reverse cardiovascular senescence,” Methodist DeBakey Cardiovascular Journal, vol. 11, no. 3, pp. 172–175, 2015. View at Publisher · View at Google Scholar
  56. M. Zurek, J. Altschmied, S. Kohlgrüber, N. Ale-Agha, and J. Haendeler, “Role of telomerase in the cardiovascular system,” Genes, vol. 7, no. 6, p. 29, 2016. View at Publisher · View at Google Scholar · View at Scopus
  57. D. Harman, “Aging: a theory based on free radical and radiation chemistry,” Journal of Gerontology, vol. 11, no. 3, pp. 298–300, 1956. View at Publisher · View at Google Scholar
  58. B. Skibska and A. Goraca, “The protective effect of lipoic acid on selected cardiovascular diseases caused by age-related oxidative stress,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 313021, 11 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  59. J. Wu, S. Xia, B. Kalionis, W. Wan, and T. Sun, “The role of oxidative stress and inflammation in cardiovascular aging,” BioMed Research International, vol. 2014, Article ID 615312, 13 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  60. J. Lapointe and S. Hekimi, “When a theory of aging ages badly,” Cellular and Molecular Life Sciences, vol. 67, no. 1, pp. 1–8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. S. Hekimi, J. Lapointe, and Y. Wen, “Taking a good look at free radicals in the aging process,” Trends in Cell Biology, vol. 21, no. 10, pp. 569–576, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. S. Hekimi, Y. Wang, and A. Noë, “Mitochondrial ROS and the effectors of the intrinsic apoptotic pathway in aging cells: the discerning killers!,” Frontiers in Genetics, vol. 7, no. 161, 2016. View at Publisher · View at Google Scholar · View at Scopus
  63. K. Cervantes Gracia, D. Llanas-Cornejo, and H. Husi, “CVD and oxidative stress,” Journal of Clinical Medicine, vol. 6, no. 2, p. 22, 2017. View at Publisher · View at Google Scholar
  64. K. M. Holmstrom and T. Finkel, “Cellular mechanisms and physiological consequences of redox-dependent signalling,” Nature Reviews Molecular Cell Biology, vol. 15, no. 6, pp. 411–421, 2014. View at Publisher · View at Google Scholar · View at Scopus
  65. H. Cai and D. G. Harrison, “Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress,” Circulation Research, vol. 87, no. 10, pp. 840–844, 2000. View at Publisher · View at Google Scholar
  66. D. I. Brown and K. K. Griendling, “Regulation of signal transduction by reactive oxygen species in the cardiovascular system,” Circulation Research, vol. 116, no. 3, pp. 531–549, 2015. View at Publisher · View at Google Scholar · View at Scopus
  67. C. Peng, X. Wang, J. Chen et al., “Biology of ageing and role of dietary antioxidants,” BioMed Research International, vol. 2014, Article ID 831841, 13 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  68. T. W. Kensler, N. Wakabayashi, and S. Biswal, “Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway,” Annual Review of Pharmacology and Toxicology, vol. 47, no. 1, pp. 89–116, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. C. Gorrini, I. S. Harris, and T. W. Mak, “Modulation of oxidative stress as an anticancer strategy,” Nature Reviews Drug Discovery, vol. 12, no. 12, pp. 931–947, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. V. Conti, G. Corbi, V. Simeon et al., “Aging-related changes in oxidative stress response of human endothelial cells,” Aging Clinical and Experimental Research, vol. 27, no. 4, pp. 547–553, 2015. View at Publisher · View at Google Scholar · View at Scopus
  71. M. Santillo, A. Colantuoni, P. Mondola, B. Guida, and S. Damiano, “NOX signaling in molecular cardiovascular mechanisms involved in the blood pressure homeostasis,” Frontiers in Physiology, vol. 6, p. 194, 2015. View at Publisher · View at Google Scholar · View at Scopus
  72. A. C. Montezano and R. M. Touyz, “Reactive oxygen species, vascular Noxs, and hypertension: focus on translational and clinical research,” Antioxidants & Redox Signaling, vol. 20, no. 1, pp. 164–182, 2013. View at Publisher · View at Google Scholar · View at Scopus
  73. A. Schramm, P. Matusik, G. Osmenda, and T. J. Guzik, “Targeting NADPH oxidases in vascular pharmacology,” Vascular Pharmacology, vol. 56, no. 5-6, pp. 216–231, 2012. View at Publisher · View at Google Scholar · View at Scopus
  74. B. Lassègue, A. San Martín, and K. K. Griendling, “Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system,” Circulation Research, vol. 110, no. 10, pp. 1364–1390, 2012. View at Publisher · View at Google Scholar · View at Scopus
  75. S. Sriramula and J. Francis, “Tumor necrosis factor - alpha is essential for angiotensin II-induced ventricular remodeling: role for oxidative stress,” PloS One, vol. 10, no. 9, article e0138372, 2015. View at Publisher · View at Google Scholar · View at Scopus
  76. A. C. Montezano, A. Nguyen Dinh Cat, F. J. Rios, and R. M. Touyz, “Angiotensin II and vascular injury,” Current Hypertension Reports, vol. 16, no. 6, p. 431, 2014. View at Publisher · View at Google Scholar · View at Scopus
  77. G.-H. Liu, J. Qu, and X. Shen, “NF-κB/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK,” Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol. 1783, no. 5, pp. 713–727, 2008. View at Publisher · View at Google Scholar · View at Scopus
  78. D.-F. Dai, Y. A. Chiao, D. J. Marcinek, H. H. Szeto, and P. S. Rabinovitch, “Mitochondrial oxidative stress in aging and healthspan,” Longevity & Healthspan, vol. 3, no. 1, p. 6, 2014. View at Publisher · View at Google Scholar
  79. D. Harman, “The biologic clock: the mitochondria?” Journal of the American Geriatrics Society, vol. 20, no. 4, pp. 145–147, 1972. View at Publisher · View at Google Scholar · View at Scopus
  80. B. J. North and D. A. Sinclair, “The intersection between aging and cardiovascular disease,” Circulation Research, vol. 110, no. 8, pp. 1097–1108, 2012. View at Publisher · View at Google Scholar · View at Scopus
  81. J. M. V. Raamsdonk and S. Hekimi, “Deletion of the mitochondrial superoxide dismutase sod-2 extends lifespan in Caenorhabditis elegans,” PLoS Genetics, vol. 5, no. 2, article e1000361, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. F. Scialò, A. Sriram, D. Fernández-Ayala et al., “Mitochondrial ROS produced via reverse electron transport extend animal lifespan,” Cell Metabolism, vol. 23, no. 4, pp. 725–734, 2016. View at Publisher · View at Google Scholar · View at Scopus
  83. R. J. Mockett, A.-C. V. Bayne, L. K. Kwong, W. C. Orr, and R. S. Sohal, “Ectopic expression of catalase in Drosophila mitochondria increases stress resistance but not longevity,” Free Radical Biology and Medicine, vol. 34, no. 2, pp. 207–217, 2003. View at Publisher · View at Google Scholar · View at Scopus
  84. V. I. Pérez, H. V. Remmen, A. Bokov, C. J. Epstein, J. Vijg, and A. Richardson, “The overexpression of major antioxidant enzymes does not extend the lifespan of mice,” Aging Cell, vol. 8, no. 1, pp. 73–75, 2009. View at Publisher · View at Google Scholar · View at Scopus
  85. Y. Zhang, Y. Ikeno, W. Qi et al., “Mice deficient in both Mn superoxide dismutase and glutathione peroxidase-1 have increased oxidative damage and a greater incidence of pathology but no reduction in longevity,” The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol. 64A, no. 12, pp. 1212–1220, 2009. View at Publisher · View at Google Scholar · View at Scopus
  86. C. E. Schaar, D. J. Dues, K. K. Spielbauer et al., “Mitochondrial and cytoplasmic ROS have opposing effects on lifespan,” PLoS Genetics, vol. 11, no. 2, article e1004972, 2015. View at Publisher · View at Google Scholar · View at Scopus
  87. E. A. Veal, A. M. Day, and B. A. Morgan, “Hydrogen peroxide sensing and signaling,” Molecular Cell, vol. 26, no. 1, pp. 1–14, 2007. View at Publisher · View at Google Scholar · View at Scopus
  88. V. Conti, V. Izzo, G. Corbi et al., “Antioxidant supplementation in the treatment of aging-associated diseases,” Frontiers in Pharmacology, vol. 7, p. 24, 2016. View at Publisher · View at Google Scholar · View at Scopus
  89. E. Shafique, W. C. Choy, Y. Liu et al., “Oxidative stress improves coronary endothelial function through activation of the pro-survival kinase AMPK,” Aging, vol. 5, no. 7, pp. 515–530, 2013. View at Publisher · View at Google Scholar
  90. C. Franceschi and J. Campisi, “Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases,” The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol. 69, Supplement 1, pp. S4–S9, 2014. View at Publisher · View at Google Scholar · View at Scopus
  91. B. Hae-Ok, L. Young-Kyoung, K. Jeong-Min, and Y. Gyesoon, “From cell senescence to age-related diseases: differential mechanisms of action of senescence-associated secretory phenotypes,” BMB Reports, vol. 48, no. 10, pp. 549–558, 2015. View at Publisher · View at Google Scholar · View at Scopus
  92. J.-P. Coppé, P.-Y. Desprez, A. Krtolica, and J. Campisi, “The senescence-associated secretory phenotype: the dark side of tumor suppression,” Annual Review of Pathology: Mechanisms of Disease, vol. 5, no. 1, pp. 99–118, 2010. View at Publisher · View at Google Scholar · View at Scopus
  93. T. Minamino and I. Komuro, “Vascular cell senescence: contribution to atherosclerosis,” Circulation Research, vol. 100, no. 1, pp. 15–26, 2007. View at Publisher · View at Google Scholar · View at Scopus
  94. B. Fougère, E. Boulanger, F. Nourhashémi, S. Guyonnet, and M. Cesari, “Chronic inflammation: accelerator of biological aging,” The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2016. View at Publisher · View at Google Scholar
  95. S.-A. Manea, A. Constantin, G. Manda, S. Sasson, and A. Manea, “Regulation of Nox enzymes expression in vascular pathophysiology: focusing on transcription factors and epigenetic mechanisms,” Redox Biology, vol. 5, pp. 358–366, 2015. View at Publisher · View at Google Scholar · View at Scopus
  96. N. Sallam and I. Laher, “Exercise modulates oxidative stress and inflammation in aging and cardiovascular diseases,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 7239639, 32 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  97. C.-C. Lin, W.-N. Lin, R.-L. Cho, C.-y. Wang, L.-D. Hsiao, and C.-M. Yang, “TNF-α-induced cPLA2 expression via NADPH oxidase/reactive oxygen species-dependent NF-κB cascade on human pulmonary alveolar epithelial cells,” Frontiers in Pharmacology, vol. 7, no. 447, 2016. View at Publisher · View at Google Scholar · View at Scopus
  98. C.-C. Lin, C.-C. Yang, C.-Y. Wang et al., “NADPH oxidase/ROS-dependent VCAM-1 induction on TNF-α-challenged human cardiac fibroblasts enhances monocyte adhesion,” Frontiers in Pharmacology, vol. 6, no. 310, 2016. View at Publisher · View at Google Scholar · View at Scopus
  99. M. E. Matzkin, J. G. Miquet, Y. Fang et al., “Alterations in oxidative, inflammatory and apoptotic events in short-lived and long-lived mice testes,” Aging (Albany New York), vol. 8, no. 1, pp. 95–110, 2016. View at Publisher · View at Google Scholar
  100. M. R. Bennett, S. Sinha, and G. K. Owens, “Vascular smooth muscle cells in atherosclerosis,” Circulation Research, vol. 118, no. 4, pp. 692–702, 2016. View at Publisher · View at Google Scholar · View at Scopus
  101. M. Wang, R. E. Monticone, and E. G. Lakatta, “Proinflammation of aging central arteries,” Gerontology, vol. 60, no. 6, pp. 519–529, 2014. View at Publisher · View at Google Scholar · View at Scopus
  102. M. A. Gimbrone and G. García-Cardeña, “Endothelial cell dysfunction and the pathobiology of atherosclerosis,” Circulation Research, vol. 118, no. 4, pp. 620–636, 2016. View at Publisher · View at Google Scholar · View at Scopus
  103. S. C. Gupta, C. Sundaram, S. Reuter, and B. B. Aggarwal, “Inhibiting NF-κB activation by small molecules as a therapeutic strategy,” Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, vol. 1799, no. 10–12, pp. 775–787, 2010. View at Publisher · View at Google Scholar · View at Scopus
  104. J. Nunnari and A. Suomalainen, “Mitochondria: in sickness and in health,” Cell, vol. 148, no. 6, pp. 1145–1159, 2012. View at Publisher · View at Google Scholar · View at Scopus
  105. N. M. Held and R. H. Houtkooper, “Mitochondrial quality control pathways as determinants of metabolic health,” BioEssays, vol. 37, no. 8, pp. 867–876, 2015. View at Publisher · View at Google Scholar · View at Scopus
  106. M. Gonzalez-Freire, R. d. Cabo, M. Bernier et al., “Reconsidering the role of mitochondria in aging,” The Journals of Gerontology Series a: Biological Sciences and Medical Sciences, vol. 70, no. 11, pp. 1334–1342, 2015. View at Publisher · View at Google Scholar
  107. M. T. Ryan and N. J. Hoogenraad, “Mitochondrial-nuclear communications,” Annual Review of Biochemistry, vol. 76, no. 1, pp. 701–722, 2007. View at Publisher · View at Google Scholar · View at Scopus
  108. P. Mishra and D. C. Chan, “Mitochondrial dynamics and inheritance during cell division, development and disease,” Nature Reviews Molecular Cell Biology, vol. 15, no. 10, pp. 634–646, 2014. View at Publisher · View at Google Scholar · View at Scopus
  109. A. Szewczyk, W. Jarmuszkiewicz, A. Koziel et al., “Mitochondrial mechanisms of endothelial dysfunction,” Pharmacological Reports, vol. 67, no. 4, pp. 704–710, 2015. View at Publisher · View at Google Scholar · View at Scopus
  110. M. G. Rosca and C. L. Hoppel, “Mitochondrial dysfunction in heart failure,” Heart Failure Reviews, vol. 18, no. 5, pp. 607–622, 2013. View at Publisher · View at Google Scholar · View at Scopus
  111. J. R. Friedman and J. Nunnari, “Mitochondrial form and function,” Nature, vol. 505, no. 7483, pp. 335–343, 2014. View at Publisher · View at Google Scholar · View at Scopus
  112. E. F. Fang, M. Scheibye-Knudsen, K. F. Chua, M. P. Mattson, D. L. Croteau, and V. A. Bohr, “Nuclear DNA damage signalling to mitochondria in ageing,” Nature Reviews Molecular Cell Biology, vol. 17, no. 5, pp. 308–321, 2016. View at Publisher · View at Google Scholar · View at Scopus
  113. M. A. Kluge, J. L. Fetterman, and J. A. Vita, “Mitochondria and endothelial function,” Circulation Research, vol. 112, no. 8, pp. 1171–1188, 2013. View at Publisher · View at Google Scholar · View at Scopus
  114. R. Ventura-Clapier, A. Garnier, V. Veksler, and F. Joubert, “Bioenergetics of the failing heart,” Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol. 1813, no. 7, pp. 1360–1372, 2011. View at Publisher · View at Google Scholar · View at Scopus
  115. A. P. Gomes, N. L. Price, A. J. Y. Ling et al., “Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging,” Cell, vol. 155, no. 7, pp. 1624–1638, 2013. View at Publisher · View at Google Scholar · View at Scopus
  116. S.-J. Lee, A. B. Hwang, and C. Kenyon, “Inhibition of respiration extends C. elegans life span via reactive oxygen species that increase HIF-1 activity,” Current Biology, vol. 20, no. 23, pp. 2131–2136, 2010. View at Publisher · View at Google Scholar · View at Scopus
  117. S.-i. Imai and L. Guarente, “NAD+ and sirtuins in aging and disease,” Trends in Cell Biology, vol. 24, no. 8, pp. 464–471, 2014. View at Publisher · View at Google Scholar · View at Scopus
  118. H. Zhang, D. Ryu, Y. Wu et al., “NAD+ repletion improves mitochondrial and stem cell function and enhances life span in mice,” Science, vol. 352, no. 6292, pp. 1436–1443, 2016. View at Publisher · View at Google Scholar · View at Scopus
  119. J. Marín-García and A. T. Akhmedov, “Mitochondrial dynamics and cell death in heart failure,” Heart Failure Reviews, vol. 21, no. 2, pp. 123–136, 2016. View at Publisher · View at Google Scholar · View at Scopus
  120. Z. Shen, C. Ye, K. McCain, and M. L. Greenberg, “The role of cardiolipin in cardiovascular health,” BioMed Research International, vol. 2015, Article ID 891707, 12 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  121. S.-B. Ong, S. B. Kalkhoran, S. Hernández-Reséndiz, P. Samangouei, S.-G. Ong, and D. J. Hausenloy, “Mitochondrial-shaping proteins in cardiac health and disease—the long and the short of it!,” Cardiovascular Drugs and Therapy, vol. 31, no. 1, pp. 87–107, 2017. View at Publisher · View at Google Scholar
  122. D. A. Brown, J. B. Perry, M. E. Allen et al., “Expert consensus document: mitochondrial function as a therapeutic target in heart failure,” Nature Reviews Cardiology, vol. 14, no. 4, pp. 238–250, 2017. View at Publisher · View at Google Scholar · View at Scopus
  123. C. D. Duve and R. Wattiaux, “Functions of lysosomes,” Annual Review of Physiology, vol. 28, pp. 435–492, 1966. View at Publisher · View at Google Scholar
  124. J. D. Rabinowitz and E. White, “Autophagy and metabolism,” Science, vol. 330, no. 6009, pp. 1344–1348, 2010. View at Publisher · View at Google Scholar · View at Scopus
  125. K. H. Kim and M.-S. Lee, “Autophagy—a key player in cellular and body metabolism,” Nature Reviews Endocrinology, vol. 10, no. 6, pp. 322–337, 2014. View at Publisher · View at Google Scholar · View at Scopus
  126. O. Lenoir, P.-L. Tharaux, and T. B. Huber, “Autophagy in kidney disease and aging: lessons from rodent models,” Kidney International, vol. 90, no. 5, pp. 950–964, 2016. View at Publisher · View at Google Scholar · View at Scopus
  127. L. Santambrogio and A. Cuervo, “Chasing the elusive mammalian microautophagy,” Autophagy, vol. 7, no. 6, pp. 652–654, 2011. View at Publisher · View at Google Scholar · View at Scopus
  128. W. Li, Q. Yang, and Z. Mao, “Chaperone-mediated autophagy: machinery, regulation and biological consequences,” Cellular and Molecular Life Sciences, vol. 68, no. 5, pp. 749–763, 2011. View at Publisher · View at Google Scholar · View at Scopus
  129. R. C. Russell, H.-X. Yuan, and K.-L. Guan, “Autophagy regulation by nutrient signaling,” Cell Research, vol. 24, no. 1, pp. 42–57, 2014. View at Publisher · View at Google Scholar · View at Scopus
  130. J. Lee, S. Giordano, and J. Zhang, “Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling,” Biochemical Journal, vol. 441, no. 2, pp. 523–540, 2012. View at Publisher · View at Google Scholar · View at Scopus
  131. C. Riehle and E. D. Abel, “Insulin regulation of myocardial autophagy,” Circulation Journal, vol. 78, no. 11, pp. 2569–2576, 2014. View at Publisher · View at Google Scholar
  132. A. Shirakabe, Y. Ikeda, S. Sciarretta, D. K. Zablocki, and J. Sadoshima, “Aging and autophagy in the heart,” Circulation Research, vol. 118, no. 10, pp. 1563–1576, 2016. View at Publisher · View at Google Scholar · View at Scopus
  133. S. Xu, Y. Cai, and Y. Wei, “mTOR signaling from cellular senescence to organismal aging,” Aging and Disease, vol. 5, no. 4, pp. 263–273, 2014. View at Publisher · View at Google Scholar · View at Scopus
  134. M. Markaki and N. Tavernarakis, “Metabolic control by target of rapamycin and autophagy during ageing - a mini-review,” Gerontology, vol. 59, no. 4, pp. 340–348, 2013. View at Publisher · View at Google Scholar · View at Scopus
  135. G. Jia, A. R. Aroor, L. A. Martinez-Lemus, and J. R. Sowers, “Overnutrition, mTOR signaling, and cardiovascular diseases,” American Journal of Physiology - Regulatory, Integrative and Comparative Physiology, vol. 307, no. 10, pp. R1198–R1206, 2014. View at Publisher · View at Google Scholar · View at Scopus
  136. G. R. Y. D. Meyer and W. Martinet, “Autophagy in the cardiovascular system,” Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol. 1793, no. 9, pp. 1485–1495, 2009. View at Publisher · View at Google Scholar · View at Scopus
  137. Y. Ikeda, S. Sciarretta, N. Nagarajan et al., “New insights into the role of mitochondrial dynamics and autophagy during oxidative stress and aging in the heart,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 210934, 13 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  138. J. M. Phillip, I. Aifuwa, J. Walston, and D. Wirtz, “The mechanobiology of aging,” Annual Review of Biomedical Engineering, vol. 17, pp. 113–141, 2015. View at Publisher · View at Google Scholar · View at Scopus
  139. N. E. Seah, C. D. d. Magalhaes Filho, A. P. Petrashen et al., “Autophagy-mediated longevity is modulated by lipoprotein biogenesis,” Autophagy, vol. 12, no. 2, pp. 261–272, 2016. View at Publisher · View at Google Scholar · View at Scopus
  140. S. M. Solon-Biet, S. J. Mitchell, R. d. Cabo, D. Raubenheimer, D. G. L. Couteur, and S. J. Simpson, “Macronutrients and caloric intake in health and longevity,” Journal of Endocrinology, vol. 226, no. 1, pp. R17–R28, 2015. View at Publisher · View at Google Scholar · View at Scopus
  141. C. D. Wiley and J. Campisi, “From ancient pathways to aging cells-connecting metabolism and cellular senescence,” Cell Metabolism, vol. 23, no. 6, pp. 1013–1021, 2016. View at Publisher · View at Google Scholar · View at Scopus
  142. X. Sun, T. Komatsu, J. Lim et al., “Nutrient-dependent requirement for SOD1 in lifespan extension by protein restriction in Drosophila melanogaster,” Aging Cell, vol. 11, no. 5, pp. 783–793, 2012. View at Publisher · View at Google Scholar
  143. A. Chandrasekaran, M. D. Idelchik, and J. A. Melendez, “Redox control of senescence and age-related disease,” Redox Biology, vol. 11, pp. 91–102, 2017. View at Publisher · View at Google Scholar
  144. S. Milman, G. Atzmon, D. M. Huffman et al., “Low insulin-like growth factor-1 level predicts survival in humans with exceptional longevity,” Aging Cell, vol. 13, no. 4, pp. 769–771, 2014. View at Publisher · View at Google Scholar · View at Scopus
  145. A. E. Webb and A. Brunet, “FOXO transcription factors: key regulators of cellular quality control,” Trends in Biochemical Sciences, vol. 39, no. 4, pp. 159–169, 2014. View at Publisher · View at Google Scholar · View at Scopus
  146. Y. Wang, Y. Zhou, and D. T. Graves, “FOXO transcription factors: their clinical significance and regulation,” BioMed Research International, vol. 2014, Article ID 925350, 13 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  147. L.-O. Klotz, C. Sánchez-Ramos, I. Prieto-Arroyo, P. Urbánek, H. Steinbrenner, and M. Monsalve, “Redox regulation of FoxO transcription factors,” Redox Biology, vol. 6, pp. 51–72, 2015. View at Publisher · View at Google Scholar · View at Scopus
  148. R. Martins, G. J. Lithgow, and W. Link, “Long live FOXO: unraveling the role of FOXO proteins in aging and longevity,” Aging Cell, vol. 15, no. 2, pp. 196–207, 2016. View at Publisher · View at Google Scholar · View at Scopus
  149. S. Sciarretta, M. Volpe, and J. Sadoshima, “mTOR signaling in cardiac physiology and disease: Sciarretta et al. mTOR signaling in the cardiovascular system,” Circulation Research, vol. 114, no. 3, pp. 549–564, 2014. View at Publisher · View at Google Scholar · View at Scopus
  150. T. Nacarelli, A. Azar, and C. Sell, “Aberrant mTOR activation in senescence and aging: a mitochondrial stress response?” Experimental Gerontology, vol. 68, pp. 66–70, 2015. View at Publisher · View at Google Scholar · View at Scopus
  151. D.-F. Dai, P. P. Karunadharma, Y. A. Chiao et al., “Altered proteome turnover and remodeling by short-term caloric restriction or rapamycin rejuvenate the aging heart,” Aging Cell, vol. 13, no. 3, pp. 529–539, 2014. View at Publisher · View at Google Scholar · View at Scopus
  152. K. Burkewitz, H. J. M. Weir, and W. B. Mair, “AMPK as a pro-longevity target,” in AMP-Activated Protein Kinase, M. D. Cordero and B. Viollet, Eds., pp. 227–256, Springer International Publishing, Cham, 2016. View at Publisher · View at Google Scholar
  153. D. G. Hardie, “AMPK: positive and negative regulation, and its role in whole-body energy homeostasis,” Current Opinion in Cell Biology, vol. 33, pp. 1–7, 2015. View at Publisher · View at Google Scholar · View at Scopus
  154. D. G. Hardie, F. A. Ross, and S. A. Hawley, “AMPK: a nutrient and energy sensor that maintains energy homeostasis,” Nature Reviews Molecular Cell Biology, vol. 13, no. 4, pp. 251–262, 2012. View at Publisher · View at Google Scholar · View at Scopus
  155. A. Martin-Montalvo, E. M. Mercken, S. J. Mitchell et al., “Metformin improves healthspan and lifespan in mice,” Nature Communications, vol. 4, article 2192, 2013. View at Publisher · View at Google Scholar · View at Scopus
  156. S.-i. Imai and L. Guarente, “It takes two to tango: NAD+ and sirtuins in aging/longevity control,” Npj Aging and Mechanisms of Disease, vol. 2, article 16017, 2016. View at Publisher · View at Google Scholar
  157. S. Srivastava, “Emerging therapeutic roles for NAD+ metabolism in mitochondrial and age-related disorders,” Clinical and Translational Medicine, vol. 5, no. 1, pp. 1–11, 2016. View at Publisher · View at Google Scholar
  158. J. A. Hall, J. E. Dominy, Y. Lee, and P. Puigserver, “The sirtuin family’s role in aging and age-associated pathologies,” The Journal of Clinical Investigation, vol. 123, no. 3, pp. 973–979, 2013. View at Publisher · View at Google Scholar · View at Scopus
  159. M. C. Haigis and D. A. Sinclair, “Mammalian sirtuins: biological insights and disease relevance,” Annual Review of Pathology, vol. 5, 2010. View at Publisher · View at Google Scholar · View at Scopus
  160. G. Favero, L. Franceschetti, L. F. Rodella, and R. Rezzani, “Sirtuins, aging, and cardiovascular risks,” Age, vol. 37, no. 4, p. 65, 2015. View at Publisher · View at Google Scholar · View at Scopus
  161. T. Yamamoto, J. Byun, P. Zhai, Y. Ikeda, S. Oka, and J. Sadoshima, “Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion,” PloS One, vol. 9, no. 6, article e98972, 2014. View at Publisher · View at Google Scholar · View at Scopus
  162. C.-P. Hsu, I. Odewale, R. Alcendor Ralph, and J. Sadoshima, “Sirt1 protects the heart from aging and stress,” Biological Chemistry, vol. 389, no. 3, pp. 221–231, 2008. View at Publisher · View at Google Scholar · View at Scopus
  163. J. Liu, C. Zhang, W. Hu, and Z. Feng, “Tumor suppressor p53 and its mutants in cancer metabolism,” Cancer Letters, vol. 356, no. 2, pp. 197–203, 2015. View at Publisher · View at Google Scholar · View at Scopus
  164. O. D. K. Maddocks and K. H. Vousden, “Metabolic regulation by p53,” Journal of Molecular Medicine, vol. 89, no. 3, pp. 237–245, 2011. View at Publisher · View at Google Scholar · View at Scopus
  165. A. Rufini, P. Tucci, I. Celardo, and G. Melino, “Senescence and aging: the critical roles of p53,” Oncogene, vol. 32, no. 43, pp. 5129–5143, 2013. View at Publisher · View at Google Scholar · View at Scopus
  166. F. Schwartzenberg-Bar-Yoseph, M. Armoni, and E. Karnieli, “The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression,” Cancer Research, vol. 64, no. 7, pp. 2627–2633, 2004. View at Publisher · View at Google Scholar · View at Scopus
  167. K. H. Vousden and K. M. Ryan, “p53 and metabolism,” Nature Reviews Cancer, vol. 9, no. 10, pp. 691–700, 2009. View at Publisher · View at Google Scholar · View at Scopus
  168. K. Kawauchi, K. Araki, K. Tobiume, and N. Tanaka, “p53 regulates glucose metabolism through an IKK-NF-[kappa]B pathway and inhibits cell transformation,” Nature Cell Biology, vol. 10, no. 5, pp. 611–618, 2008. View at Publisher · View at Google Scholar · View at Scopus
  169. P. Jiang, W. Du, and X. Yang, “p53 and regulation of tumor metabolism,” Journal of Carcinogenesis, vol. 12, p. 21, 2013. View at Publisher · View at Google Scholar · View at Scopus
  170. C.-P. Kung and M. E. Murphy, “The role of the p53 tumor suppressor in metabolism and diabetes,” Journal of Endocrinology, vol. 231, no. 2, pp. R61–R75, 2016. View at Publisher · View at Google Scholar · View at Scopus
  171. S. Matoba, J.-G. Kang, W. D. Patino et al., “p53 regulates mitochondrial respiration,” Science, vol. 312, no. 5780, pp. 1650–1653, 2006. View at Publisher · View at Google Scholar · View at Scopus
  172. C. Zhang, M. Lin, R. Wu et al., “Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect,” Proceedings of the National Academy of Sciences, vol. 108, no. 39, pp. 16259–16264, 2011. View at Publisher · View at Google Scholar · View at Scopus
  173. F. Kruiswijk, C. F. Labuschagne, and K. H. Vousden, “p53 in survival, death and metabolic health: a lifeguard with a licence to kill,” Nature Reviews Molecular Cell Biology, vol. 16, no. 7, pp. 393–405, 2015. View at Publisher · View at Google Scholar · View at Scopus
  174. C. R. Berkers, O. D. K. Maddocks, E. C. Cheung, I. Mor, and K. H. Vousden, “Metabolic regulation by p53 family members,” Cell Metabolism, vol. 18, no. 5, pp. 617–633, 2013. View at Publisher · View at Google Scholar · View at Scopus
  175. Y. A. Chiao and P. S. Rabinovitch, “The aging heart,” Cold Spring Harbor Perspectives in Medicine, vol. 5, no. 9, 2015. View at Publisher · View at Google Scholar · View at Scopus
  176. D.-F. Dai, T. Chen, S. C. Johnson, H. Szeto, and P. S. Rabinovitch, “Cardiac aging: from molecular mechanisms to significance in human health and disease,” Antioxidants & Redox Signaling, vol. 16, no. 12, pp. 1492–1526, 2012. View at Publisher · View at Google Scholar · View at Scopus
  177. F. Paneni, C. Diaz Cañestro, P. Libby, T. F. Lüscher, and G. G. Camici, “The aging cardiovascular system: understanding it at the cellular and clinical levels,” Journal of the American College of Cardiology, vol. 69, no. 15, pp. 1952–1967, 2017. View at Publisher · View at Google Scholar
  178. E. G. Lakatta, “So! What’s aging? Is cardiovascular aging a disease?” Journal of Molecular and Cellular Cardiology, vol. 83, pp. 1–13, 2015. View at Publisher · View at Google Scholar · View at Scopus
  179. G. Santulli and G. Iaccarino, “Adrenergic signaling in heart failure and cardiovascular aging,” Maturitas, vol. 93, pp. 65–72, 2016. View at Publisher · View at Google Scholar · View at Scopus
  180. K.-T. Kang, “Endothelium-derived relaxing factors of small resistance arteries in hypertension,” Toxicological Research, vol. 30, no. 3, pp. 141–148, 2014. View at Publisher · View at Google Scholar · View at Scopus
  181. M. A. Ozkor and A. A. Quyyumi, “Endothelium-derived hyperpolarizing factor and vascular function,” Cardiology Research and Practice, vol. 2011, Article ID 156146, 12 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  182. T. P. Ribeiro, A. C. Oliveira, L. G. Mendes-Junior et al., “Cardiovascular effects induced by northeastern Brazilian red wine: role of nitric oxide and redox sensitive pathways,” Journal of Functional Foods, vol. 22, pp. 82–92, 2016. View at Publisher · View at Google Scholar · View at Scopus
  183. R. F. Furchgott and P. M. Vanhoutte, “Endothelium-derived relaxing and contracting factors,” The FASEB Journal, vol. 3, no. 9, pp. 2007–2018, 1989. View at Publisher · View at Google Scholar · View at Scopus
  184. Z. Ungvari, G. Kaley, R. d. Cabo, W. E. Sonntag, and A. Csiszar, “Mechanisms of vascular aging: new perspectives,” The Journals of Gerontology Series a: Biological Sciences and Medical Sciences, vol. 65A, no. 10, pp. 1028–1041, 2010. View at Publisher · View at Google Scholar · View at Scopus
  185. A. Valerio and E. Nisoli, “Nitric oxide, interorganelle communication, and energy flow: a novel route to slow aging,” Frontiers in Cell and Developmental Biology, vol. 3, no. 6, 2015. View at Publisher · View at Google Scholar
  186. T. Michel and P. M. Vanhoutte, “Cellular signaling and NO production,” Pflugers Archiv : European Journal of Physiology, vol. 459, no. 6, pp. 807–816, 2010. View at Publisher · View at Google Scholar · View at Scopus
  187. S. Novella, A. P. Dantas, G. Segarra et al., “Aging-related endothelial dysfunction in the aorta from female senescence-accelerated mice is associated with decreased nitric oxide synthase expression,” Experimental Gerontology, vol. 48, no. 11, pp. 1329–1337, 2013. View at Publisher · View at Google Scholar · View at Scopus
  188. A. E. Vendrov, K. C. Vendrov, A. Smith et al., “NOX4 NADPH oxidase-dependent mitochondrial oxidative stress in aging-associated cardiovascular disease,” Antioxidants & Redox Signaling, vol. 23, no. 18, pp. 1389–1409, 2015. View at Publisher · View at Google Scholar · View at Scopus
  189. D. R. Seals, R. E. Kaplon, R. A. Gioscia-Ryan, and T. J. LaRocca, “You're only as old as your arteries: translational strategies for preserving vascular endothelial function with aging,” Physiology, vol. 29, no. 4, pp. 250–264, 2014. View at Publisher · View at Google Scholar · View at Scopus
  190. H.-Y. Lee and B.-H. Oh, “Aging and arterial stiffness,” Circulation Journal, vol. 74, no. 11, pp. 2257–2262, 2010. View at Google Scholar
  191. B. V. Varik, R. Rennenberg, C. Reutelingsperger, A. Kroon, P. de Leeuw, and L. Schurgers, “Mechanisms of arterial remodeling: lessons from genetic diseases,” Frontiers in Genetics, vol. 3, no. 290, 2012. View at Publisher · View at Google Scholar · View at Scopus
  192. M. Wang and A. M. Shah, “Age-associated pro-inflammatory remodeling and functional phenotype in the heart and large arteries,” Journal of Molecular and Cellular Cardiology, vol. 83, pp. 101–111, 2015. View at Publisher · View at Google Scholar · View at Scopus
  193. C. Meschiari, O. K. Ero, H. Pan, T. Finkel, and M. L. Lindsey, “The impact of aging on cardiac extracellular matrix,” GeroScience, vol. 39, no. 1, pp. 7–18, 2017. View at Publisher · View at Google Scholar
  194. M. AlGhatrif, M. Wang, O. V. Fedorova, A. Y. Bagrov, and E. G. Lakatta, “The pressure of aging,” Medical Clinics of North America, vol. 101, no. 1, pp. 81–101, 2017. View at Publisher · View at Google Scholar
  195. G. J. Brewer, “Epigenetic oxidative redox shift (EORS) theory of aging unifies the free radical and insulin signaling theories,” Experimental Gerontology, vol. 45, no. 3, pp. 173–179, 2010. View at Publisher · View at Google Scholar · View at Scopus
  196. A. Cannatà, G. Marcon, G. Cimmino et al., “Role of circulating factors in cardiac aging,” Journal of Thoracic Disease, vol. 9, Supplement 1, pp. S17–S29, 2017. View at Publisher · View at Google Scholar
  197. L. Katsimpardi, N. K. Litterman, P. A. Schein et al., “Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors,” Science, vol. 344, no. 6184, pp. 630–634, 2014. View at Publisher · View at Google Scholar · View at Scopus
  198. P. L. Minciullo, A. Catalano, G. Mandraffino et al., “Inflammaging and anti-inflammaging: the role of cytokines in extreme longevity,” Archivum Immunologiae et Therapiae Experimentalis, vol. 64, no. 2, pp. 111–126, 2016. View at Publisher · View at Google Scholar · View at Scopus
  199. I. Gregersen, S. Holm, T. B. Dahl, B. Halvorsen, and P. Aukrust, “A focus on inflammation as a major risk factor for atherosclerotic cardiovascular diseases,” Expert Review of Cardiovascular Therapy, vol. 14, no. 3, pp. 391–403, 2016. View at Publisher · View at Google Scholar · View at Scopus
  200. F. S. Loffredo, M. L. Steinhauser, S. M. Jay et al., “Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy,” Cell, vol. 153, no. 4, pp. 828–839, 2013. View at Publisher · View at Google Scholar · View at Scopus
  201. Y. Maruyama, “Aging and arterial-cardiac interactions in the elderly,” International Journal of Cardiology, vol. 155, no. 1, pp. 14–19, 2012. View at Publisher · View at Google Scholar · View at Scopus
  202. A. J. Donato, R. G. Morgan, A. E. Walker, and L. A. Lesniewski, “Cellular and molecular biology of aging endothelial cells,” Journal of Molecular and Cellular Cardiology, vol. 89, Part B, pp. 122–135, 2015. View at Publisher · View at Google Scholar · View at Scopus
  203. C. Steyers and F. Miller, “Endothelial dysfunction in chronic inflammatory diseases,” International Journal of Molecular Sciences, vol. 15, no. 7, article 11324, 2014. View at Publisher · View at Google Scholar · View at Scopus
  204. N. Panth, K. R. Paudel, and K. Parajuli, “Reactive oxygen species: a key hallmark of cardiovascular disease,” Advances in Medicine, vol. 2016, Article ID 9152732, 12 pages, 2016. View at Publisher · View at Google Scholar